封面
市场调查报告书
商品编码
1621407

软胶囊市场:按类型、应用和分销管道划分 - 全球预测 2025-2030

Softgel Capsules Market by Type (Gelatin, Non-Animal), Application (Cosmetics, Health Supplements, Pharmaceuticals), Distribution Channel - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年软胶囊市值为41.7亿美元,预计2024年将达到44.8亿美元,复合年增长率为7.71%,到2030年将达到70.2亿美元。

软胶囊是广泛用于製药和营养品食品的口服剂型,其特征是将液体或固体填充物封装在明胶壳中。由于改善的生物有效性、易于吞嚥和消费者便利性,软胶囊市场的范围已经扩大,需要作为各种活性成分的首选递送系统。根据应用,它们用于营养食品、处方药和非处方药。最终用途范围广泛,涵盖製药、食品和化妆品领域。市场的关键成长要素包括消费者对营养食品的偏好不断增加、对个人化医疗的需求以及植物明胶和稳定性增强配方等胶囊技术的进步。该行业的潜在机会包括大麻二酚(CBD)领域的扩大应用、人口老化需要先进的药物输送系统以及对预防性医疗保健的日益关注。为了利用这些优势,市场相关人员应专注于配方透明度、明胶的素食替代品以及与新兴市场的合作等创新。然而,市场面临严格的法律规范、原材料价格波动以及来自锭剂和注射剂等替代给药系统的竞争等挑战。此外,软胶囊对大气条件敏感,因此稳定性有限。对于寻求创新的公司来说,提高胶囊完整性、开发生物分解性材料和增强遮罩技术等领域提供了利润丰厚的机会。市场是动态的,在不断的产品创新和不断提高的客户期望的推动下具有竞争性。投资研发以克服现有挑战并抓住新机会的公司可能会在这个不断变化的环境中取得成功。

主要市场统计
基准年[2023] 41.7亿美元
预计年份 [2024] 44.8亿美元
预测年份 [2030] 70.2亿美元
复合年增长率(%) 7.71%

市场动态:快速发展的软胶囊市场的关键市场洞察

供需的动态交互作用正在改变软胶囊市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大软胶囊在食品产业的使用
    • 用法用量 软胶囊的用法用量
    • 消费者对健康和美容补充品的偏好日益增长
  • 市场限制因素
    • 人们对软胶囊高生产成本和标准品质的不满日益增加
  • 市场机会
    • 软胶囊製造和包装的技术进步
    • 线上药局平台的全球普及
  • 市场挑战
    • 与软胶囊相关的操作和製造复杂性

波特五力:驾驭软胶囊市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解软胶囊市场的外部影响

外部宏观环境因素在塑造软胶囊市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解软胶囊市场的竞争格局

软胶囊市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵软胶囊市场供应商的绩效评估

FPNV 定位矩阵是评估软胶囊市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商,从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议,以规划软胶囊市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,对软胶囊市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开发:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 软胶囊越来越多地用于食品产业
      • 使用软胶囊达到目标剂量
      • 消费者对保健和化妆品补充品的偏好日益增长
    • 抑制因素
      • 製造成本飙升,人们对软胶囊标准品质的不满情绪日益增长
    • 机会
      • 软胶囊製造和包装的技术进步
      • 线上药局平台在全球越来越受欢迎
    • 任务
      • 与软胶囊相关的操作和製造复杂性
  • 市场区隔分析
    • 类型:各类软胶囊
    • 应用领域:广泛应用于各产业
    • 分销管道:透过多种分销管道提高市场渗透率
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章软胶囊市场:依类型

  • 明胶
  • 非动物的

第七章软胶囊市场:依应用

  • 化妆品
  • 保健补充品
  • 药品

第八章软胶囊市场:按分销管道

  • 医院药房
  • 网路药房
  • 零售药房
  • 超级市场

第九章美洲软胶囊市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区软胶囊市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲软胶囊市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争情境分析
    • Lee Health Domain 在海德拉巴推出「D-Macura」软胶囊
    • Teva 将印度製造工厂出售给 Mark Sands
    • Vitafoods Europe 2023:IFF 推出用于营养食品的纯素软胶囊
    • CVC Technologies 宣布收购 Chansung 软胶囊系统
  • 战略分析和建议

公司名单

  • Aenova Group GmbH
  • Amway Corporation
  • BASF SE
  • Captek Softgel International Inc
  • Catalent, Inc.
  • Curtis Health Caps
  • Delpharm
  • Elnova Pharma
  • Fortunelabs
  • Fuji Capsules Co Ltd.
  • Hunan Kang Pharmaceutical Limited
  • InovoBiologic Inc.
  • International Flavors & Fragrances Inc.
  • Marksans Pharma Limited
  • Natural Factors
  • Nature's Bounty Co.
  • Qualicaps Co., Ltd.
  • Rocket Science Supplements Ltd.
  • Roquette Freres
  • SaintyCo
  • Sirio Pharma Co., Ltd. by Pfizer Inc.
  • Soft Gel Technologies, Inc.
  • Softigel by Procaps Group
  • Strides Pharma Science Limited
  • Thermo Fisher Scientific, Inc.
  • Trigen Laboratories Inc.
  • United Laboratories
  • Weihai Baihe Biology Technological Co Ltd.
  • Yuwang Group
Product Code: MRR-4103B31E08B4

The Softgel Capsules Market was valued at USD 4.17 billion in 2023, expected to reach USD 4.48 billion in 2024, and is projected to grow at a CAGR of 7.71%, to USD 7.02 billion by 2030.

Softgel capsules are a form of oral dosage used widely in the pharmaceutical and nutraceutical industries, characterized by a gelatin-based shell enclosing a liquid or semi-solid fill. The scope of the softgel capsules market stretches across their necessity as preferred delivery systems for various active ingredients due to improved bioavailability, ease of swallowing, and consumer convenience. Application-wise, they are employed in dietary supplements, prescription medications, and over-the-counter products. The end-use scope is broad, spanning pharmaceuticals, nutraceuticals, and cosmetics sectors. Key growth influencers in the market include the rising consumer preference for nutraceuticals, demand for personalized medicine, and advancements in capsule technology, such as plant-based gelatin and stability-enhanced formulations. Potential opportunities unfolding in the industry include expanding applications in the cannabidiol (CBD) segment, growing aging populations requiring advanced drug delivery systems, and increasing inclination towards preventive healthcare. To capitalize on these, market players need to focus on innovations in formulation transparency, vegan alternatives to gelatin, and partnerships with emerging markets. However, the market does face challenges such as stringent regulatory frameworks, fluctuations in raw material prices, and competition from alternative drug delivery systems like tablets and injections. Moreover, the sensitivity of softgel capsules to atmospheric conditions poses a limitation on their stability. For businesses aiming at innovation, areas like improving capsule integrity, developing biodegradable materials, and enhancing taste-masking techniques present lucrative possibilities. The market is dynamic with a competitive nature driven by constant product innovation and rising customer expectations. Companies that invest in research and development to overcome existing challenges and capture emerging opportunities are likely to thrive in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 4.17 billion
Estimated Year [2024] USD 4.48 billion
Forecast Year [2030] USD 7.02 billion
CAGR (%) 7.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Softgel Capsules Market

The Softgel Capsules Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing applications of soft gel capsules in nutraceutical industries
    • Usage of softgel capsules for targeted dosages
    • Rise in consumer preference for health and cosmetic supplements
  • Market Restraints
    • High-cost of manufacturing soft gel capsules and increasing dissatisfaction in standard quality
  • Market Opportunities
    • Technological advancements in manufacturing and packaging of softgel capsules
    • Rising penetration of online pharmacy platforms worldwide
  • Market Challenges
    • Operational and manufacturing complexities associated with soft gel capsules

Porter's Five Forces: A Strategic Tool for Navigating the Softgel Capsules Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Softgel Capsules Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Softgel Capsules Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Softgel Capsules Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Softgel Capsules Market

A detailed market share analysis in the Softgel Capsules Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Softgel Capsules Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Softgel Capsules Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Softgel Capsules Market

A strategic analysis of the Softgel Capsules Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Softgel Capsules Market, highlighting leading vendors and their innovative profiles. These include Aenova Group GmbH, Amway Corporation, BASF SE, Captek Softgel International Inc, Catalent, Inc., Curtis Health Caps, Delpharm, Elnova Pharma, Fortunelabs, Fuji Capsules Co Ltd., Hunan Kang Pharmaceutical Limited, InovoBiologic Inc., International Flavors & Fragrances Inc., Marksans Pharma Limited, Natural Factors, Nature's Bounty Co., Qualicaps Co., Ltd., Rocket Science Supplements Ltd., Roquette Freres, SaintyCo, Sirio Pharma Co., Ltd. by Pfizer Inc., Soft Gel Technologies, Inc., Softigel by Procaps Group, Strides Pharma Science Limited, Thermo Fisher Scientific, Inc., Trigen Laboratories Inc., United Laboratories, Weihai Baihe Biology Technological Co Ltd., and Yuwang Group.

Market Segmentation & Coverage

This research report categorizes the Softgel Capsules Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Gelatin and Non-Animal.
  • Based on Application, market is studied across Cosmetics, Health Supplements, and Pharmaceuticals.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, and Supermarket Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing applications of soft gel capsules in nutraceutical industries
      • 5.1.1.2. Usage of softgel capsules for targeted dosages
      • 5.1.1.3. Rise in consumer preference for health and cosmetic supplements
    • 5.1.2. Restraints
      • 5.1.2.1. High-cost of manufacturing soft gel capsules and increasing dissatisfaction in standard quality
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in manufacturing and packaging of softgel capsules
      • 5.1.3.2. Rising penetration of online pharmacy platforms worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Operational and manufacturing complexities associated with soft gel capsules
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: of various types of softgel capsules
    • 5.2.2. Application: Wide scope of applications across industries
    • 5.2.3. Distribution Channel: Enhanced market penetration through multiple distribution channels
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Softgel Capsules Market, by Type

  • 6.1. Introduction
  • 6.2. Gelatin
  • 6.3. Non-Animal

7. Softgel Capsules Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetics
  • 7.3. Health Supplements
  • 7.4. Pharmaceuticals

8. Softgel Capsules Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies
  • 8.5. Supermarket Stores

9. Americas Softgel Capsules Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Softgel Capsules Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Softgel Capsules Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Lee Health Domain Launches 'D-Macula' Soft Gel Capsules in Hyderabad
    • 12.3.2. Teva wraps up sale of India manufacturing facility to Marksans
    • 12.3.3. Vitafoods Europe 2023: IFF to Launch Vegan Softgel Capsule For Nutraceuticals
    • 12.3.4. CVC Technologies has Announced the Acquisition of Changsung Softgel System
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aenova Group GmbH
  • 2. Amway Corporation
  • 3. BASF SE
  • 4. Captek Softgel International Inc
  • 5. Catalent, Inc.
  • 6. Curtis Health Caps
  • 7. Delpharm
  • 8. Elnova Pharma
  • 9. Fortunelabs
  • 10. Fuji Capsules Co Ltd.
  • 11. Hunan Kang Pharmaceutical Limited
  • 12. InovoBiologic Inc.
  • 13. International Flavors & Fragrances Inc.
  • 14. Marksans Pharma Limited
  • 15. Natural Factors
  • 16. Nature's Bounty Co.
  • 17. Qualicaps Co., Ltd.
  • 18. Rocket Science Supplements Ltd.
  • 19. Roquette Freres
  • 20. SaintyCo
  • 21. Sirio Pharma Co., Ltd. by Pfizer Inc.
  • 22. Soft Gel Technologies, Inc.
  • 23. Softigel by Procaps Group
  • 24. Strides Pharma Science Limited
  • 25. Thermo Fisher Scientific, Inc.
  • 26. Trigen Laboratories Inc.
  • 27. United Laboratories
  • 28. Weihai Baihe Biology Technological Co Ltd.
  • 29. Yuwang Group

LIST OF FIGURES

  • FIGURE 1. SOFTGEL CAPSULES MARKET RESEARCH PROCESS
  • FIGURE 2. SOFTGEL CAPSULES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SOFTGEL CAPSULES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SOFTGEL CAPSULES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SOFTGEL CAPSULES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SOFTGEL CAPSULES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SOFTGEL CAPSULES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SOFTGEL CAPSULES MARKET DYNAMICS
  • TABLE 7. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY NON-ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY HEALTH SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SOFTGEL CAPSULES MARKET SIZE, BY SUPERMARKET STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES SOFTGEL CAPSULES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA SOFTGEL CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM SOFTGEL CAPSULES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM SOFTGEL CAPSULES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM SOFTGEL CAPSULES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. SOFTGEL CAPSULES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. SOFTGEL CAPSULES MARKET, FPNV POSITIONING MATRIX, 2023